• Perifosine (KRX-0401): Applied Workflows in Akt Pathway Inhi

  2026-06-09

  Perifosine (KRX-0401) empowers researchers with precision control over apoptosis and Akt/mTOR signaling, streamlining apoptosis assays and radiosensitization workflows in cancer models. This guide translates evidence-based protocols and troubleshooting strategies into actionable insights for robust, reproducible, and advanced experimental designs.

• Deferoxamine Mesylate: Iron-Chelating Agent for Advanced Res

  2026-06-08

  Deferoxamine mesylate (APExBIO SKU B6068) stands out as a versatile iron-chelating agent, powering workflows from tumor inhibition to hypoxia-mimetic assays. Learn how its unique properties enable precise oxidative stress control, robust HIF-1α stabilization, and actionable insights for troubleshooting complex experiments.

• Octyl-α-ketoglutarate: Optimizing Prolyl Hydroxylase Substra

  2026-06-08

  Octyl-α-ketoglutarate enables precise manipulation of intracellular α-KG levels in cancer metabolism studies, especially where TCA dysfunction or IDH mutations drive HIF-1α stabilization. This APExBIO reagent streamlines hypoxia pathway workflows and empowers troubleshooting in metabolic reprogramming assays.

• L-NMMA Acetate (SKU B6444): Reliable NOS Pathway Modulation

  2026-06-07

  This scenario-driven guide addresses real laboratory challenges in nitric oxide pathway research, focusing on the application of L-NMMA acetate (SKU B6444) for cell viability, proliferation, and cytotoxicity assays. Scientists will find practical, data-backed insights into optimizing experimental design, protocol precision, and reagent selection—grounded in recent literature and the robust quality profile of APExBIO’s L-NMMA acetate.

• JHU-083: Unlocking Glutaminase Inhibition in Neurological Mo

  2026-06-06

  Explore the unique role of JHU-083, a 6-diazo-5-oxo-L-norleucine precursor, as a selective glutaminase antagonist for advanced neurological disease model research. This article delivers a deep dive into mechanism, protocol design, and the translational significance of glutaminase inhibition.

• HyperScribe T7 High Yield Cy5 RNA Labeling Kit: Workflow & T

  2026-06-05

  The HyperScribe T7 High Yield Cy5 RNA Labeling Kit empowers researchers with efficient, tunable fluorescent RNA probe synthesis for high-sensitivity in situ hybridization and Northern blot workflows. Its flexible Cy5-UTP incorporation and robust yields address common probe preparation challenges while supporting advanced experimental designs.

• Indole-3-pyruvic Acid: A Molecular Nexus in Plant and Immune

  2026-06-05

  Explore how Indole-3-pyruvic acid (IPA) orchestrates auxin biosynthesis and immune modulation at the molecular level, with insights that go beyond protocols to reveal deeper mechanistic and translational implications for plant and biomedical research.

• HotStart Universal 2X FAST Green qPCR Master Mix: Precision

  2026-06-04

  Harness the speed and specificity of HotStart Universal 2X FAST Green qPCR Master Mix for robust gene expression workflows, even in inhibitor-rich plant or clinical samples. This advanced dye-based reagent integrates a mutant hot-start Taq polymerase and universal ROX normalization, enabling reliable quantification and streamlined melt curve analysis—all backed by recent breakthroughs in plant molecular biology.

• FTSJ3 Loss Drives R-Loop DNA Damage and Chemosensitivity in

  2026-06-04

  This study identifies FTSJ3 as a crucial regulator of R-loop homeostasis in lung cancer cells. Loss of FTSJ3 leads to increased R-loop-associated DNA damage, promoting chemosensitivity and highlighting new avenues for therapeutic intervention.

• 3-Deazaneplanocin (DZNep): Epigenetic Modulation in Oncology

  2026-06-03

  3-Deazaneplanocin (DZNep) stands out as a dual-action epigenetic modulator, enabling precise targeting of cancer stem cells and robust apoptosis induction in various cancer models. This article details practical workflows, advanced applications, and troubleshooting strategies for maximizing DZNep’s performance in translational oncology and metabolic disease research.

• Tin Mesoporphyrin IX (chloride): Reliable HO Inhibition in C

  2026-06-03

  This article addresses real laboratory challenges in heme oxygenase studies, focusing on how Tin Mesoporphyrin IX (chloride) (SKU C5606) enables reproducible, sensitive inhibition for cell viability and metabolic disease workflows. Drawing on validated protocols and recent literature, it guides researchers through assay design, data interpretation, and product selection to maximize reliability and experimental impact.

• Pharmacokinetics and Pulmonary Distribution of Gamithromycin

  2026-06-02

  This study systematically characterizes the pharmacokinetics, tissue distribution, and antimicrobial activity of Gamithromycin (ML-1709460) in foals, highlighting its prolonged presence and high concentrations in lung-associated compartments and phagocytic cells. These findings inform the rational use of Gamithromycin as a long-acting macrolide antibiotic for respiratory infections in veterinary models.

• ATRX-Deficient Glioma Sensitivity to RTK/PDGFR Inhibition

  2026-06-02

  Pladevall-Morera et al. reveal that high-grade glioma cells lacking ATRX are markedly more sensitive to receptor tyrosine kinase (RTK) and PDGFR inhibitors, suggesting ATRX status as a key determinant for therapeutic response. This finding opens new avenues for personalized strategies and underscores the need to stratify glioma patients by ATRX genotype in clinical research.

• HyperTrap Heparin HP Column: Precision Protein Purification

  2026-06-01

  The HyperTrap Heparin HP Column leverages high-density HyperChrom Heparin HP Agarose to deliver unparalleled resolution in isolating coagulation factors and stemness-related proteins. Its robust chemical stability and compatibility with demanding workflows make it a trusted tool for cancer research and advanced protein purification.

• DNA Damage Pathways and CLM Sensitivity in Acute Leukemia Mo

  2026-06-01

  This study applies genome-wide CRISPR/Cas9 screening to uncover how DNA damage sensing and TP53 function modulate leukemia cell sensitivity to calicheamicin-based antibody–drug conjugates (ADCs). The findings highlight the central roles of TP53, ATM, and MDM2 in determining cellular response, informing future strategies for improving ADC efficacy in acute leukemia.

669 records 10/45 page Previous Next First page 上5页 678910 下5页 Last page